MK0354

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0354, covering 2015-05-18 to 2015-05-18. Get the full timeline:

Most recent: Clinical Trial Update: MK0354 Clinical Efficacy and Tolerability Study (0354-004) [Phase 2]